Published in Health Risk Factor Week, June 5th, 2007
This trend article about Northwestern University, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A new study, "Does anti-IgE therapy help in asthma' Efficacy and controversies," is now available. "Omalizumab, a humanized monoclonal antibody against IgE, is clinically efficacious when it neutralizes almost all free IgE and reduces IgE receptors on basophils and mast cells. Asthmatic subjects on inhaled corticosteroids who are treated with omalizumab as an add-on therapy experience only modest benefits in symptoms and perhaps in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.